Fate Therapeutics (FATE) announced the appointment of Kamal Adawi, M.S., M.B.A., to the role of Chief Financial Officer, CFO, effective October 20, 2025. Adawi brings to the Company more than 20 years of financial leadership experience in the life sciences industry.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks